Fundraise comps

47 of 417 showing · Series B

Date Company Context Round Valuation Revenue Source
  • 2026-08
    W Wispr view Series B
    Menlo Ventures Artificial intelligence Voice AI; dictation; speech models
    $280M
    post $2.0B EV/Rev
    site src
  • 2026-08
    H Higgsfield view Series B
    DST Global Artificial intelligence AI video generation; creator tools; enterprise marketing
    $400M
    post $5.4B EV/Rev
    site src
  • 2026-08
    C Convex view Series B
    Insight Partners, Spark Capital and Andreessen Horowitz Enterprise software commercial services software
    $57M
    post EV/Rev
    site src
  • 2026-08
    A Amplifica view Series B
    Tasso Partners Biotech Hair growth therapeutics
    $26M
    post EV/Rev
    site src
  • 2026-08
    K Khartis Therapeutics view Series B
    Forge Life Science Partners Biotech Oral medicines for immunological and chronic diseases
    $50M
    post EV/Rev
    site src
  • 2026-08
    A Aureka Biotechnologies view Series B
    Granite Asia Biotech Biological foundation models for drug discovery
    $100M
    post EV/Rev
    site src
  • 2026-08
    Y Yuno view Series B
    Global PayTech Payments infrastructure + tags
    $45M
    post EV/Rev
    site src
  • 2026-08
    H Heaviside Industries view Series B
    Felicis, Hedosophia and Menlo Defense technology defense hardware
    $60M
    post EV/Rev
    site src
  • 2026-08
    I InduPro view Series B
    Column, Vida, MRL, Emerson and Lilly Biotech oncology
    $77M
    post EV/Rev
    site src
  • 2026-08
    B Blacksmith view Series B
    Peak XV, GV and YC Developer tools AI code testing
    $45M
    post EV/Rev
    site src
  • 2026-08
    O OLIX Computing view Series B
    Fundomo Semiconductors photonic AI chips optical tensor processing units
    $312M
    post $3.3B EV/Rev
    site src
  • 2026-08
    V Valar Atomics view Series B
    Sequoia Energy microreactors; data center power
    $1.0B
    post $6.0B EV/Rev
    site src
  • 2026-08
    V Vaderis Therapeutics view Series B
    Goldman Sachs Alternatives, TCGX, Omega and EQT Biotech rare vascular disease
    $152M
    post EV/Rev
    site src
  • 2026-08
    P Point2 Technology view Series B
    Infrastructure data-center interconnect
    $60M
    post EV/Rev
    site src
  • 2026-08
    M Meduloc view Series B
    GenHenn Healthcare Orthopedic devices
    $4M
    post EV/Rev
    site src
  • 2026-08
    M Multiplier view Series B
    General Partnership Professional services Professional-services platform
    $35M
    post EV/Rev
    site src
  • 2026-08
    O Omilia view Series B
    Expedition Growth Enterprise software Agentic customer experience
    $67M
    post EV/Rev
    site src
  • 2026-08
    A Acrab view Series B
    Vertex SEA & India and Vertex Growth AI infrastructure Agentic-AI compute infrastructure
    $130M
    post EV/Rev
    site src
  • 2026-08
    Q QuantHealth view Series B
    Qumra and Pitango Healthcare Clinical-trial simulation
    $45M
    post EV/Rev
    site src
  • 2026-08
    W WindBorne Systems view Series B
    Khosla and Galvanize Climate Weather balloons
    $37M
    post EV/Rev
    site src
  • 2026-08
    W Wellinks view Series B
    UMass Memorial Healthcare Cardiopulmonary care
    $10M
    post EV/Rev
    site src
  • 2026-08
    A Ambrook view Series B
    Lachy Groom Fintech Agriculture bookkeeping
    $30M
    post EV/Rev
    site src
  • 2026-08
    E Expedition Therapeutics view Series B
    General Atlantic Healthcare Oral therapies
    $115M
    post EV/Rev
    site src
  • 2026-08
    W Wordsmith AI view Series B
    Intact Legaltech AI legal
    $14M
    post EV/Rev
    site src
  • 2026-08
    O Olix view Series B
    Fundomo Semiconductors AI chips inference chips
    $312M
    post $3.3B EV/Rev
    site src
  • 2026-08
    M Mariana Minerals view Series B
    Mining technology critical minerals mining technology
    $310M
    post $1.5B EV/Rev
    site src
  • 2026-07
    F Freehand view Series B
    Enterprise software Enterprise AI and supply-chain automation
    $75M
    post EV/Rev
    site src
  • 2026-07
    S Simile view Series B
    Digital twins of individuals + tags
    $200M
    post EV/Rev
    site src
  • 2026-07
    D DataBahn view Series B
    Data-pipeline platform + tags
    $40M
    post EV/Rev
    site src
  • 2026-07
    G Greyparrot view Series B
    Omar Mir Climate waste intelligence
    $27M
    post EV/Rev
    site src
  • 2026-07
    A Alpen view Series B
    Inherent Climate high-efficiency windows
    $6M
    post EV/Rev
    site src
  • 2026-07
    Q Qureight view Series B
    Molten Healthcare clinical-trials imaging
    $20M
    post EV/Rev
    site src
  • 2026-07
    C Claros Technologies view Series B
    Treehouse Climate PFAS destruction
    $55M
    post EV/Rev
    site src
  • 2026-07
    D Dwelly view Series B
    EQT Growth and General Catalyst Residential lettings + tags
    $95M
    post EV/Rev
    site src
  • 2026-07
    C Claris Bio view Series B
    Samsara BioCapital and Catalio Capital Management Biotechnology + tags
    $118M
    post EV/Rev
    site src
  • 2026-07
    C Crystalys Therapeutics view Series B
    biotech + tags
    $130M
    post EV/Rev
    site src
  • 2026-07
    S Stuut view Series B
    AR automation + tags
    post EV/Rev
    site src
  • 2026-07
    G Glow view Series B
    endpoint security + tags
    $100M
    post $1.2B EV/Rev
    site src
  • 2026-07
    A Augustus view Series B
    AI/stablecoin clearing bank + tags
    $180M
    post EV/Rev
    site src
  • 2026-07
    A Autoridad Panandina view Series B
    AI infrastructure/energy + tags
    post EV/Rev
    site src
  • 2026-07
    N Nava view Series B
    AI infrastructure/neocloud + tags
    post EV/Rev
    site src
  • 2026-07
    D Databento view Series B
    NEA Fintech + tags
    $97M
    post EV/Rev
    site src
  • 2026-07
    F Fasset view Series B
    Fintech Crypto
    $51M
    post EV/Rev
    site src
  • 2026-07
    H Hilo Health view Series B
    Healthtech + tags
    $19M
    post EV/Rev
    site src
  • 2026-07
    S Senra Systems view Series B
    Hardware + tags
    $65M
    post EV/Rev
    site src
  • 2026-07
    R RapidPulse view Series B
    Healthtech + tags
    $48M
    post EV/Rev
    site src
  • 2026-07
    C CuspAI view Series B
    AI / ML + tags
    $450M
    post $2.6B EV/Rev
    site src